Retigabine (D-23129) [N-(2-amino-3-(4-fluorobenzylamino)phenyl) carbamic ac
id ethyl ester] is a novel antiepileptic drug. The compound was shown to po
ssess anticonvulsant properties both in vivo and in vitro. We investigated
the effects of retigabine on neurones in the rat medial entorhinal cortex u
sing conventional intracellular recordings in combined hippocampal-entorhin
al cortex slices. Retigabine strongly reduced the number of action potentia
ls elicited by 1 s long depolarising current injections. Both the amplitude
s of monosynaptic inhibitory postsynaptic potentials/currents (IPSP/Cs) and
the amplitudes of excitatory postsynaptic potentials (EPSPs) remained unaf
fected. The drug increased outward rectification and induced a membrane-pot
ential hyperpolarisation in most of the tested neurones. The findings sugge
st that retigabine exerts its anticonvulsant effects by activation of a Kconductance, however it cannot be excluded from our experiments that other
mechanisms may be involved in the effect of retigabine on membrane properti
es. (C) 1999 Elsevier Science B.V. All rights reserved.